<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02548247</url>
  </required_header>
  <id_info>
    <org_study_id>BTS528_10</org_study_id>
    <nct_id>NCT02548247</nct_id>
  </id_info>
  <brief_title>Effect of Consumption of Orafti® Inulin on Bowel Motor Function in Subjects With Constipation</brief_title>
  <official_title>Effect of Consumption of Inulin on Bowel Motor Function in Subjects With Constipation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beneo GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beneo GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of the effects of a four week daily consumption of Orafti® Inulin on bowel
      motor function in subjects with constipation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stool frequency determined by daily questionnaire</measure>
    <time_frame>4 weeks</time_frame>
    <description>Stool frequency determined by daily questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stool consistency rated according to the Bristol Stool Form Scale</measure>
    <time_frame>4 weeks</time_frame>
    <description>Stool consistency rated according to the Bristol Stool Form Scale from Type 1 to Type 7.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire on Gastrointestinal characteristics</measure>
    <time_frame>4 weeks</time_frame>
    <description>Sensation of straining, abdominal discomfort, bloating/distension, passage of gas and feeling of incomplete emptying rated on a 5-point scale (0 = not at all, 1 = very slightly, 2 = slightly, 3 = moderately, 4 = extremely).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire on Participant Assessment of Constipation Quality of Life (PAC-QoL)</measure>
    <time_frame>4 weeks</time_frame>
    <description>Severity of each symptom rated on a five-point scale from 0 (not at all / none of the time) to 4 (extremely / all of the time).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faecal microbiota composition determined by illumina sequencing</measure>
    <time_frame>4 weeks</time_frame>
    <description>Determined by illumina sequencing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool metabolite profiling determined by GC/LC-MS</measure>
    <time_frame>4 weeks</time_frame>
    <description>Determined by GC/LC-MS.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Healthy</condition>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>Orafti® Inulin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily consumption of 12g Orafti® Inulin (3x 4g/d) over a period of 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Daily consumption of 12g/ Maltodextrin (3x 4g/d) over a period of 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Orafti® Inulin</intervention_name>
    <description>Dietary fiber</description>
    <arm_group_label>Orafti® Inulin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Maltodextrin</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers without clinical diagnosed diseases with relevant effect on the
             gastrointestinal system or on visceral motility.

          -  Constipation defined as an average of 2-3 stools per week. Volunteers should have had
             constipation for at least the previous 6 months.

          -  Age ≥ 20 and ≤ 75

        Exclusion Criteria:

          -  Subject under prescription for medication for digestive symptoms such as
             antispasmodic, laxatives, anti-diarrheic drugs or other digestive auxiliaries.

          -  Relevant history, presence of any medical disorder or chronic intake of
             medication/dietary supplements potentially interfering with this trial.

          -  Subjects with stool frequency of &lt;1 stool every 7 days or more than 3 stools per week.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Menzel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>BioTeSys GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>BioTeSys GmbH</name>
      <address>
        <city>Esslingen</city>
        <zip>73728</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2015</study_first_submitted>
  <study_first_submitted_qc>September 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2015</study_first_posted>
  <last_update_submitted>September 11, 2015</last_update_submitted>
  <last_update_submitted_qc>September 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stool frequency</keyword>
  <keyword>Bowel motor function</keyword>
  <keyword>Orafti® Inulin</keyword>
  <keyword>Dietary Fiber</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

